Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChemomab Therapeutics Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Chemomab Therapeutics Ltd. Earnings Date And Information
Chemomab Therapeutics Ltd. last posted its earnings results on Wednesday, August 21st, 2024. The company reported $-0.26 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Chemomab Therapeutics Ltd. has generated $-2 earnings per share over the last year ($-2.06 diluted earnings per share) and currently has a price-to-earnings ratio of -2.3. Chemomab Therapeutics Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Chemomab Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.20 | $0 | $0 | ||
| 08/21/2024 | Q2 2024 | -$0.20 | -$0.25 | -0.05 | $0 | $0 |
| 03/29/2024 | Q1 2024 | -$0.28 | $0 | |||
| 03/28/2024 | Q4 2023 | -$0.27 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.60 | -$0.34 | 0.26 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.80 | -$0.72 | 0.08 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.80 | -$0.79 | 0.01 | $0 | |
| 03/20/2023 | Q4 2022 | -$0.80 | -$0.71 | 0.09 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.73 | $0 | |||
| 08/12/2022 | Q2 2022 | -$0.60 | -$0.54 | 0.06 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.40 | -$0.45 | -0.05 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.41 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.15 | -$0.26 | -0.12 | $0 | |
| 08/13/2021 | Q2 2021 | -$0.12 | -$0.26 | -0.15 | $0 | |
| 05/13/2021 | Q1 2021 | -$0.43 | -$0.22 | 0.21 | $0 | |
| 03/09/2021 | Q4 2020 | -$0.18 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.11 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.10 | $0 | |||
| 05/07/2020 | Q1 2020 | -$1.84 | -$0.15 | 1.69 | $0 | |
| 11/21/2019 | Q4 2019 | $0.00 | $0 |
Chemomab Therapeutics Ltd. Earnings: FAQ's
When is Chemomab Therapeutics Ltd.'s earnings date?
Chemomab Therapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
How can I listen to Chemomab Therapeutics Ltd.'s earnings conference
call?
The conference call for Chemomab Therapeutics Ltd.'s latest earnings report can be listened to online.
How can I read Chemomab Therapeutics Ltd.'s conference call transcript?
The conference call transcript for Chemomab Therapeutics Ltd.'s latest earnings report can be read online.
How much profit does Chemomab Therapeutics Ltd. generate each year?
Chemomab Therapeutics Ltd. (:CMMB) has a recorded net income of $0. Chemomab Therapeutics Ltd. has generated $-2.06 earnings per share over the last four quarters.
What is Chemomab Therapeutics Ltd.'s price-to-earnings ratio?
Chemomab Therapeutics Ltd. (:CMMB) has a price-to-earnings ratio of -2.3 and price/earnings-to-growth ratio is -0.19.